Last 7 days
-5.1%
Last 30 days
-9.5%
Last 90 days
-14.6%
Trailing 12 Months
77.8%
Year | Q1 | Q2 | Q3 | Q4 |
---|---|---|---|---|
2023 | 420.9M | 461.1M | 495.9M | 0 |
2022 | 258.2M | 308.7M | 375.4M | 388.8M |
2021 | 176.0M | 190.8M | 210.2M | 259.8M |
2020 | 111.4M | 121.4M | 135.7M | 156.6M |
2019 | 85.4M | 93.5M | 103.8M | 107.5M |
2018 | 40.6M | 52.7M | 71.0M | 74.6M |
2017 | 29.7M | 31.9M | 34.2M | 36.5M |
2016 | 0 | 0 | 0 | 27.4M |
Datesorted ascending | Name | Buy/Sell | $ Value | Avg. Price | # Shares | Title |
---|---|---|---|---|---|---|
Nov 29, 2023 | wang david h | sold | -1,452,660 | 17.1353 | -84,776 | see remarks |
Nov 29, 2023 | dun haiping | sold | -327,474 | 17.25 | -18,984 | - |
Nov 22, 2023 | dun haiping | sold | -264,900 | 17.66 | -15,000 | - |
Nov 22, 2023 | wang david h | sold | -1,590,750 | 17.675 | -90,000 | see remarks |
Nov 20, 2023 | liu tracy | sold | -268,650 | 17.91 | -15,000 | - |
Nov 20, 2023 | liu tracy | acquired | 110,400 | 7.36 | 15,000 | - |
Nov 14, 2023 | wang david h | sold (taxes) | -90,009 | 17.23 | -5,224 | see remarks |
Nov 14, 2023 | wang david h | acquired | 90,000 | 0.5 | 180,000 | see remarks |
Nov 14, 2023 | dun haiping | acquired | 17,500 | 0.5 | 35,000 | - |
Nov 14, 2023 | dun haiping | sold (taxes) | -17,505 | 17.23 | -1,016 | - |
Datesorted ascending | Fund Name | Type | % Chg | $ Change | $ Held | % Portfolio |
---|---|---|---|---|---|---|
Dec 06, 2023 | CITIGROUP INC | reduced | -0.73 | 8,702,100 | 31,966,600 | 0.02% |
Nov 24, 2023 | DEUTSCHE BANK AG\ | added | 14.3 | 164,478 | 446,810 | -% |
Nov 22, 2023 | Graham Capital Management, L.P. | sold off | -100 | -544,428 | - | -% |
Nov 21, 2023 | Walleye Trading LLC | reduced | -37.11 | -53,836 | 362,082 | -% |
Nov 21, 2023 | Walleye Capital LLC | sold off | -100 | -302,802 | - | -% |
Nov 16, 2023 | McIlrath & Eck, LLC | added | 72.46 | 2,504 | 4,309 | -% |
Nov 15, 2023 | GSA CAPITAL PARTNERS LLP | reduced | -43.11 | -270,000 | 999,000 | 0.09% |
Nov 15, 2023 | Penserra Capital Management LLC | new | - | 3,254,000 | 3,254,000 | 0.07% |
Nov 15, 2023 | MORGAN STANLEY | added | 160 | 7,736,930 | 10,701,600 | -% |
Nov 15, 2023 | MANUFACTURERS LIFE INSURANCE COMPANY, THE | reduced | -1.56 | 91,848 | 345,208 | -% |
Date Filed | Name of Filer | Percent of Class | No. of Shares | Form Type | |
---|---|---|---|---|---|
Jul 18, 2023 | shanghai science & technology venture capital (group) co., ltd. | 6.3% | 3,438,510 | SC 13D/A | |
Jul 18, 2023 | shanghai science & technology venture capital (group) co., ltd. | 6.3% | 3,438,510 | SC 13G/A | |
Jun 13, 2023 | shanghai science & technology venture capital (group) co., ltd. | 6.3% | 3,438,510 | SC 13D | |
Jun 13, 2023 | shanghai science & technology venture capital (group) co., ltd. | 6.3% | 3,438,510 | SC 13G | |
Feb 14, 2023 | yiheng capital management, l.p. | 9.69% | 5,266,800 | SC 13G/A | |
Feb 13, 2023 | blackrock inc. | 5.9% | 3,221,430 | SC 13G | |
Feb 09, 2023 | vanguard group inc | 5.33% | 2,899,420 | SC 13G | |
Feb 09, 2023 | morgan stanley | 0.7% | 390,606 | SC 13G/A | |
Feb 08, 2023 | morgan stanley | 5.1% | 2,773,504 | SC 13G/A | |
Feb 14, 2022 | yiheng capital management, l.p. | 8.20% | 1,415,100 | SC 13G |
Date Filed | Form Type | Document | |
---|---|---|---|
Dec 08, 2023 | 8-K | Current Report | |
Dec 01, 2023 | 4 | Insider Trading | |
Dec 01, 2023 | 4 | Insider Trading | |
Nov 29, 2023 | 144 | Notice of Insider Sale Intent | |
Nov 29, 2023 | 144 | Notice of Insider Sale Intent | |
Nov 27, 2023 | 4 | Insider Trading | |
Nov 27, 2023 | 4 | Insider Trading | |
Nov 22, 2023 | 144 | Notice of Insider Sale Intent | |
Nov 22, 2023 | 144 | Notice of Insider Sale Intent | |
Nov 22, 2023 | 4 | Insider Trading |
Name | Mkt Capsorted ascending | Revenue | Price %, 1M | Returns, 1Y | P/E | P/S | Rev 1-Yr | Inc 1-Yr |
---|---|---|---|---|---|---|---|---|
LARGE-CAP | ||||||||
NVDA | 1.2T | 44.9B | 2.01% | 176.71% | 62.2 | 26.18 | 57.07% | 217.10% |
AMD | 208.2B | 22.1B | 13.51% | 82.97% | 1.0K | 9.42 | -3.14% | -90.85% |
INTC | 180.0B | 52.9B | 12.61% | 51.97% | -109.5 | 3.41 | -23.98% | -112.36% |
AMAT | 123.8B | 26.5B | 2.42% | 36.33% | 19.21 | 4.66 | 5.50% | -3.05% |
ADI | 91.7B | 12.3B | 9.45% | 9.48% | 27.68 | 7.46 | 2.43% | 20.59% |
MID-CAP | ||||||||
AMKR | 7.1B | 6.7B | 23.06% | 6.76% | 17.39 | 1.06 | -3.65% | -50.30% |
CRUS | 4.3B | 1.8B | 9.02% | 1.07% | 30.6 | 2.45 | -10.70% | -59.88% |
ACLS | 4.0B | 1.1B | -5.85% | 49.75% | 17.32 | 3.7 | 26.38% | 43.48% |
DIOD | 3.3B | 1.8B | 7.92% | -18.08% | 11.26 | 1.8 | -7.52% | -3.55% |
AMBA | 2.3B | 290.7M | 16.64% | -27.14% | -23.52 | 7.93 | -17.79% | -146.17% |
SMALL-CAP | ||||||||
ACMR | 958.4M | 495.9M | -9.50% | 77.78% | 13.41 | 1.93 | 32.10% | 66.11% |
AEHR | 744.7M | 74.9M | 9.06% | 1.17% | 39.95 | 9.94 | 34.12% | 99.53% |
AOSL | 630.4M | 663.5M | 7.12% | -29.81% | -79.92 | 0.95 | -16.96% | -101.73% |
ATOM | 181.5M | - | 33.84% | -2.49% | -9.32 | 576.4 | -4.50% | -12.39% |
ASYS | 92.2M | 117.9M | -5.48% | -25.65% | 25.5 | 0.78 | 19.93% | -73.89% |
Income Statement (Quarterly) | (In Thousands) | |||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Description | (%) Q/Q | 2023Q3 | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 | 2020Q3 | 2020Q2 | 2020Q1 | 2019Q4 | 2019Q3 | 2019Q2 | 2019Q1 | 2018Q4 | 2018Q3 |
Revenue | 16.6% | 169 | 145 | 74.00 | 109 | 134 | 104 | 42.00 | 95.00 | 67.00 | 54.00 | 44.00 | 46.00 | 48.00 | 39.00 | 24.00 | 25.00 | 33.00 | 29.00 | 20.00 | 21.00 | 23.00 |
Cost Of Revenue | 5.4% | 80.00 | 76.00 | 34.00 | 55.00 | 68.00 | 60.00 | 23.00 | 50.00 | 37.00 | 32.00 | 26.00 | 26.00 | 27.00 | 20.00 | 14.00 | 12.00 | 17.00 | 16.00 | 12.00 | 11.00 | 13.00 |
Gross Profit | 29.0% | 89.00 | 69.00 | 40.00 | 54.00 | 66.00 | 44.00 | 20.00 | 45.00 | 30.00 | 22.00 | 18.00 | 20.00 | 20.00 | 19.00 | 10.00 | 12.00 | 16.00 | 13.00 | 9.00 | 10.00 | 10.00 |
Operating Expenses | 44.8% | 55.00 | 38.00 | 31.00 | 37.00 | 34.00 | 24.00 | 29.00 | 26.00 | 18.00 | 17.00 | 15.00 | 14.00 | 13.00 | 12.00 | 9.00 | 9.00 | 9.00 | 8.00 | 7.00 | 8.00 | 7.00 |
S&GA Expenses | 46.9% | 17.00 | 11.00 | 9.00 | 12.00 | 13.00 | 8.00 | 7.00 | 9.00 | 6.00 | 6.00 | 5.00 | 5.00 | 4.00 | 5.00 | 3.00 | 3.00 | 4.00 | 3.00 | 2.00 | 2.00 | 3.00 |
R&D Expenses | 30.3% | 26.00 | 20.00 | 14.00 | 18.00 | 16.00 | 11.00 | 17.00 | 13.00 | 8.00 | 8.00 | 6.00 | 6.00 | 4.00 | 5.00 | 4.00 | 3.00 | 3.00 | 3.00 | 3.00 | 4.00 | 2.00 |
EBITDA Margin | -11.1% | 0.22* | 0.25* | 0.23* | 0.19* | 0.21* | 0.16* | 0.13* | 0.18* | 0.15* | 0.15* | 0.13* | 0.14* | 0.13* | 0.15* | 0.19* | 0.19* | 0.20* | 0.17* | 0.16* | 0.12* | 0.12* |
Interest Expenses | -1.4% | 1.00 | 1.00 | 1.00 | 1.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Income Taxes | -90.6% | 1.00 | 8.00 | 3.00 | 3.00 | 10.00 | 8.00 | -4.01 | 3.00 | -0.27 | 0.00 | -2.77 | -2.80 | -1.75 | 2.00 | 0.00 | -1.18 | -0.33 | 1.00 | 0.00 | 0.00 | 0.00 |
Earnings Before Taxes | -23.1% | 32.00 | 41.00 | 12.00 | 17.00 | 38.00 | 24.00 | -11.45 | 22.00 | 11.00 | 7.00 | 3.00 | 6.00 | 8.00 | 2.00 | 2.00 | 3.00 | 9.00 | 5.00 | 2.00 | 2.00 | 4.00 |
EBT Margin | -12.1% | 0.20* | 0.23* | 0.22* | 0.17* | 0.19* | 0.15* | 0.11* | 0.17* | 0.13* | 0.13* | 0.11* | 0.12* | 0.12* | 0.14* | 0.17* | 0.18* | 0.18* | 0.15* | 0.14* | 0.10* | 0.12* |
Net Income | -4.3% | 26.00 | 27.00 | 7.00 | 12.00 | 21.00 | 12.00 | -5.79 | 16.00 | 10.00 | 7.00 | 5.00 | 9.00 | 9.00 | -0.08 | 2.00 | 4.00 | 9.00 | 4.00 | 2.00 | 2.00 | 4.00 |
Net Income Margin | -0.5% | 0.14* | 0.14* | 0.12* | 0.10* | 0.11* | 0.10* | 0.10* | 0.15* | 0.15* | 0.15* | 0.13* | 0.12* | 0.10* | 0.12* | 0.17* | 0.18* | 0.17* | 0.13* | 0.13* | 0.09* | 0.11* |
Free Cashflow | -9358.5% | -45.78 | -0.48 | -45.39 | -71.34 | -15.39 | -35.65 | -30.90 | -40.36 | -6.77 | -11.39 | 9.00 | -7.14 | 1.00 | -15.89 | 4.00 | 14.00 | -0.65 | -1.63 | -3.30 | 9.00 | 1.00 |
Balance Sheet | (In Millions) | |||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Description | (%) Q/Q | 2023Q3 | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 | 2020Q3 | 2020Q2 | 2020Q1 | 2019Q4 | 2019Q3 | 2019Q2 | 2019Q1 | 2018Q4 | 2018Q3 |
Assets | 7.1% | 1,410 | 1,317 | 1,313 | 1,236 | 1,148 | 1,072 | 1,087 | 1,052 | 470 | 419 | 372 | 341 | 297 | 257 | 217 | 218 | 180 | 120 | 111 | 103 | 89.00 |
Current Assets | 11.9% | 1,116 | 997 | 994 | 964 | 971 | 901 | 905 | 953 | 377 | 329 | 287 | 261 | 252 | 206 | 198 | 198 | 164 | 108 | 100 | 96.00 | 83.00 |
Cash Equivalents | -19.3% | 208 | 257 | 260 | 248 | 336 | 324 | 380 | 563 | 65.00 | 70.00 | 79.00 | 72.00 | 92.00 | 86.00 | 52.00 | 118 | 47.00 | 28.00 | 27.00 | 27.00 | 18.00 |
Inventory | 7.7% | 507 | 471 | 473 | 393 | 328 | 288 | 272 | 218 | 177 | 137 | 103 | 89.00 | 64.00 | 50.00 | 45.00 | 45.00 | 44.00 | 45.00 | 42.00 | 39.00 | 30.00 |
Net PPE | 20.0% | 191 | 159 | 150 | 83.00 | 66.00 | 57.00 | 58.00 | 14.00 | 10.00 | 9.00 | 9.00 | 8.00 | 6.00 | 4.00 | 3.00 | 4.00 | 4.00 | 3.00 | 4.00 | 4.00 | 4.00 |
Liabilities | 10.0% | 532 | 484 | 480 | 423 | 374 | 284 | 279 | 241 | 227 | 189 | 157 | 133 | 106 | 106 | 59.00 | 60.00 | 62.00 | 61.00 | 56.00 | 51.00 | 40.00 |
Current Liabilities | 5.6% | 482 | 456 | 450 | 396 | 346 | 253 | 244 | 206 | 195 | 162 | 128 | 103 | 96.00 | 97.00 | 51.00 | 54.00 | 56.00 | 53.00 | 49.00 | 46.00 | 35.00 |
Short Term Borrowings | -37.2% | 34.00 | 54.00 | 57.00 | 56.00 | 51.00 | 5.00 | 10.00 | 10.00 | 15.00 | 22.00 | 23.00 | 26.00 | 28.00 | 26.00 | 4.00 | 14.00 | 16.00 | 15.00 | 13.00 | 9.00 | 10.00 |
LT Debt, Current | 107.4% | 7.00 | 3.00 | 2.00 | 2.00 | 2.00 | 2.00 | 2.00 | 2.00 | 2.00 | 2.00 | 2.00 | 2.00 | - | - | - | - | - | - | - | - | - |
LT Debt, Non Current | 150.0% | 40.00 | 16.00 | 18.00 | 19.00 | 19.00 | 21.00 | 22.00 | 23.00 | 23.00 | 19.00 | 17.00 | 18.00 | - | - | - | - | - | - | - | - | - |
Shareholder's Equity | 26.9% | 878 | 692 | 692 | 675 | 643 | 787 | 809 | 812 | 243 | 230 | 215 | 208 | 191 | 151 | 99.00 | 97.00 | 91.00 | 60.00 | 56.00 | 52.00 | 49.00 |
Retained Earnings | 22.5% | 152 | 124 | 101 | 94.00 | 91.00 | 70.00 | 66.00 | 64.00 | 56.00 | 46.00 | 40.00 | 34.00 | 26.00 | 17.00 | 17.00 | 16.00 | 12.00 | 3.00 | -1.53 | -3.39 | -5.67 |
Additional Paid-In Capital | 1.2% | 620 | 613 | 606 | 604 | 601 | 599 | 597 | 595 | 111 | 109 | 105 | 102 | 100 | 76.00 | 84.00 | 83.00 | 83.00 | 58.00 | 57.00 | 57.00 | 56.00 |
Shares Outstanding | -100.0% | - | 60.00 | 60.00 | - | 59.00 | 59.00 | 59.00 | - | 58.00 | 57.00 | 56.00 | - | 55.00 | 54.00 | 54.00 | - | 51.00 | 48.00 | 48.00 | - | 48.00 |
Minority Interest | 5.4% | 149 | 141 | 141 | 137 | 131 | 132 | 134 | 135 | 69.00 | 69.00 | 67.00 | 67.00 | 64.00 | 61.00 | - | - | - | - | - | - | - |
Cashflow (Quarterly) | ||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Description | (%) Q/Q | 2023Q3 | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 | 2020Q3 | 2020Q2 | 2020Q1 | 2019Q4 | 2019Q3 | 2019Q2 | 2019Q1 | 2018Q4 | 2018Q3 |
Cashflow From Operations | -385.8% | -17,877,000 | 6,254,000 | -30,494,000 | 1,336,000 | -2,233,000 | -33,568,000 | -27,729,000 | -36,271,000 | -4,063,000 | -10,501,000 | 10,742,000 | -5,511,000 | 2,615,000 | -14,480,000 | 3,829,000 | 14,155,000 | -145,000 | -1,425,000 | -3,182,000 | 9,642,000 | 1,385,000 |
Share Based Compensation | 424.6% | 10,581,000 | 2,017,000 | 2,068,000 | 2,494,000 | 1,893,000 | 1,969,000 | 1,374,000 | 1,294,000 | 1,278,000 | 1,335,000 | 1,210,000 | 1,305,000 | 2,779,000 | 855,000 | 689,000 | 653,000 | 1,557,000 | 618,000 | 744,000 | 592,000 | 411,000 |
Cashflow From Investing | -1860.7% | -48,782,000 | -2,488,000 | 49,129,000 | -108,890,000 | -6,541,000 | 6,120,000 | -156,359,000 | -5,803,000 | -2,693,000 | -1,206,000 | -1,578,000 | -35,297,000 | -3,501,000 | -31,034,000 | -118,000 | -237,000 | -4,789,000 | -389,000 | -116,000 | -123,000 | -909,000 |
Cashflow From Financing | -26.1% | 3,599,000 | 4,869,000 | -1,455,000 | 9,435,000 | 41,407,000 | -4,999,000 | 28,000 | 539,071,000 | -976,000 | 2,051,000 | -1,380,000 | 18,276,000 | 3,261,000 | 20,856,000 | -9,559,000 | 28,270,000 | 53,326,000 | 2,588,000 | 3,261,000 | -491,000 | 418,000 |
Buy Backs | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 9,715,000 | - | 2,042,000 | 2,827,000 | - | - | - | - |
Condensed Consolidated Statements of Operations and Comprehensive Income (Loss) - USD ($) $ in Thousands | 3 Months Ended | 9 Months Ended | ||
---|---|---|---|---|
Sep. 30, 2023 | Sep. 30, 2022 | Sep. 30, 2023 | Sep. 30, 2022 | |
Income Statement [Abstract] | ||||
Revenue (note 3) | $ 168,569 | $ 133,709 | $ 387,402 | $ 280,290 |
Cost of revenue (note 16) | 80,055 | 67,742 | 190,263 | 150,480 |
Gross profit | 88,514 | 65,967 | 197,139 | 129,810 |
Operating expenses: | ||||
Sales and marketing | 16,803 | 13,133 | 37,579 | 27,494 |
Research and development | 26,151 | 15,678 | 60,244 | 44,391 |
General and administrative | 12,387 | 5,520 | 26,851 | 15,560 |
Total operating expenses | 55,341 | 34,331 | 124,674 | 87,445 |
Income from operations | 33,173 | 31,636 | 72,465 | 42,365 |
Interest income | 2,152 | 2,016 | 6,283 | 5,965 |
Interest expense | (640) | (419) | (1,984) | (986) |
Realized gain from sale of short-term investments | 656 | 1,136 | 8,569 | 1,136 |
Unrealized loss on short-term investments | (1,319) | (5,281) | (4,428) | (9,562) |
Other income (expense), net | (2,150) | 7,207 | 156 | 9,949 |
Income (loss) from equity method investments | (160) | 1,251 | 3,728 | 1,652 |
Income before income taxes | 31,712 | 37,546 | 84,789 | 50,519 |
Income tax expense (note 19) | (718) | (10,470) | (11,235) | (14,138) |
Net income | 30,994 | 27,076 | 73,554 | 36,381 |
Less: Net income attributable to non-controlling interests | 5,315 | 6,072 | 13,905 | 8,927 |
Net income attributable to ACM Research, Inc. | 25,679 | 21,004 | 59,649 | 27,454 |
Net income available to common stockholders, diluted | 25,218 | 20,683 | 58,311 | 26,989 |
Comprehensive income (loss): | ||||
Net income | 30,994 | 27,076 | 73,554 | 36,381 |
Foreign currency translation adjustment, net of tax | 4,015 | (42,416) | (21,831) | (80,334) |
Comprehensive income (loss) | 35,009 | (15,340) | 51,723 | (43,953) |
Less: Comprehensive income (loss) attributable to non-controlling interests | 7,768 | (1,057) | 11,882 | (4,378) |
Comprehensive income (loss) attributable to ACM Research, Inc. | $ 27,241 | $ (14,283) | $ 39,841 | $ (39,575) |
Net income attributable to ACM Research, Inc. per share of common stock (note 2): | ||||
Basic (in dollars per share) | $ 0.43 | $ 0.35 | $ 0.99 | $ 0.46 |
Diluted (in dollars per share) | $ 0.39 | $ 0.32 | $ 0.90 | $ 0.41 |
Weighted average shares of common stock outstanding used in computing per share amounts (note 2): | ||||
Basic (in shares) | 60,219,218 | 59,360,790 | 59,953,144 | 59,123,895 |
Diluted (in shares) | 65,450,941 | 65,612,665 | 64,834,051 | 65,629,273 |
Condensed Consolidated Balance Sheets - USD ($) $ in Thousands | Sep. 30, 2023 | Dec. 31, 2022 |
---|---|---|
Current assets: | ||
Cash and cash equivalents (note 2) | $ 207,101 | $ 247,951 |
Restricted cash | 560 | 500 |
Short-term time deposits (note 2) | 75,651 | 70,492 |
Short-term investments (note 15) | 21,844 | 20,209 |
Accounts receivable, net (note 4) | 248,477 | 182,936 |
Inventories, net (note 5) | 507,431 | 393,172 |
Prepaid expenses | 17,540 | 15,607 |
Total current assets | 1,115,894 | 963,806 |
Property, plant and equipment, net (note 6) | 190,882 | 82,875 |
Land use right, net (note 7) | 8,299 | 8,692 |
Operating lease right-of-use assets, net (note 11) | 7,184 | 2,489 |
Intangible assets, net | 2,163 | 1,255 |
Long-term time deposits (note 2) | 43,183 | 101,956 |
Deferred tax assets (note 19) | 16,486 | 6,703 |
Long-term investments (note 14) | 22,306 | 17,459 |
Other long-term assets (note 8) | 3,851 | 50,265 |
Total assets | 1,410,248 | 1,235,500 |
Current liabilities: | ||
Other payables and accrued expenses (note 10) | 80,400 | 52,201 |
Advances from customers | 191,393 | 153,773 |
Current portion of operating lease liabilities (note 11) | 2,876 | 1,382 |
Deferred revenue | 4,747 | 4,174 |
Short-term borrowings (note 9) | 33,911 | 56,004 |
Current portion of long-term borrowings (note 12) | 6,717 | 2,322 |
Income taxes payable (note 19) | 11,061 | 3,469 |
FIN-48 payable (note 19) | 6,487 | 6,686 |
Total current liabilities | 481,951 | 396,214 |
Long-term borrowings (note 12) | 39,753 | 18,687 |
Long-term operating lease liabilities (note 11) | 4,308 | 1,107 |
Other long-term liabilities (note 13) | 6,106 | 7,321 |
Total liabilities | 532,118 | 423,329 |
Commitments and contingencies (note 20) | ||
Equity: | ||
Additional paid-in capital | 620,210 | 604,089 |
Retained earnings | 152,306 | 94,426 |
Statutory surplus reserve (note 22) | 16,881 | 16,881 |
Accumulated other comprehensive loss | (60,354) | (40,546) |
Total ACM Research, Inc. stockholders’ equity | 729,050 | 674,856 |
Non-controlling interests | 149,080 | 137,315 |
Total equity | 878,130 | 812,171 |
Total liabilities and equity | 1,410,248 | 1,235,500 |
Related Party | ||
Current assets: | ||
Other receivables | 1,164 | 3,322 |
Current liabilities: | ||
Accounts payable | 7,684 | 14,468 |
Nonrelated Party | ||
Current assets: | ||
Other receivables | 36,126 | 29,617 |
Current liabilities: | ||
Accounts payable | 136,675 | 101,735 |
Class A Common Stock | ||
Equity: | ||
Common stock | 6 | 5 |
Class B Common Stock | ||
Equity: | ||
Common stock | $ 1 | $ 1 |
CEO | Dr. Hui Wang Ph.D. |
---|---|
WEBSITE | www.acmrcsh.com |
EMPLOYEES | 1209 |